{"transactions":[{"id":4622762,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-18T20:05:09.000Z","date":"2026-09-16","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested."}],"balance_after":2148,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-108930","document":"tm2625628-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1912570/000110465926108930/tm2625628-1_4seq1.xml","form_type":"4"}},{"id":4622761,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-18T20:05:09.000Z","date":"2026-09-16","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested."}],"balance_after":2165,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-108930","document":"tm2625628-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1912570/000110465926108930/tm2625628-1_4seq1.xml","form_type":"4"}},{"id":4622760,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-18T20:05:09.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":1654,"price":153.2434,"value":253464.5836,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.78 to $153.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-108930","document":"tm2625628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1912570/000110465926108930/tm2625628-1_4seq1.xml","form_type":"4"}},{"id":4622759,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-18T20:05:09.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":989,"price":152.3617,"value":150685.7213,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.77 to $152.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":1654,"source":{"system":"sec-edgar","filing":"0001104659-26-108930","document":"tm2625628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1912570/000110465926108930/tm2625628-1_4seq1.xml","form_type":"4"}},{"id":4622758,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-18T20:05:09.000Z","date":"2026-09-16","kind":"sale","planned":true,"acquired":false,"shares":1659,"price":151.1589,"value":250772.6151,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.755 to $151.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":2643,"source":{"system":"sec-edgar","filing":"0001104659-26-108930","document":"tm2625628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1912570/000110465926108930/tm2625628-1_4seq1.xml","form_type":"4"}},{"id":4622757,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-18T20:05:09.000Z","date":"2026-09-16","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-108930","document":"tm2625628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1912570/000110465926108930/tm2625628-1_4seq1.xml","form_type":"4"}},{"id":4622756,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-18T20:05:09.000Z","date":"2026-09-16","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-108930","document":"tm2625628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1912570/000110465926108930/tm2625628-1_4seq1.xml","form_type":"4"}},{"id":679720,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested."}],"balance_after":4296,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":679719,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested."}],"balance_after":4319,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":679718,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":302,"price":156.77,"value":47344.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":679717,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":102,"price":155.5898,"value":15870.1596,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.58 to $155.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":302,"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":679716,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":400,"price":152.9975,"value":61199.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.93 to $153.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":404,"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":679715,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":1998,"price":151.7979,"value":303292.2042,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.665 to $152.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":804,"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":679714,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":151.39,"value":227085.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.62 to $151.445, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":2802,"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":679713,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":679712,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-20T20:05:17.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-099222","document":"tm2623628-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926099222/tm2623628-1_4seq1.xml","form_type":"4"}},{"id":706437,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:05:18.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested."}],"balance_after":6444,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-084620","document":"tm2620681-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926084620/tm2620681-1_4seq1.xml","form_type":"4"}},{"id":706436,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:05:18.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested."}],"balance_after":6473,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-084620","document":"tm2620681-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926084620/tm2620681-1_4seq1.xml","form_type":"4"}},{"id":706435,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-17T20:05:18.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":1911,"price":150.2529,"value":287133.2919,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.79 to $150.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-084620","document":"tm2620681-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926084620/tm2620681-1_4seq1.xml","form_type":"4"}},{"id":706434,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-17T20:05:18.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":1029,"price":149.2667,"value":153595.4343,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.79 to $149.765, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":1911,"source":{"system":"sec-edgar","filing":"0001104659-26-084620","document":"tm2620681-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926084620/tm2620681-1_4seq1.xml","form_type":"4"}},{"id":706433,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-17T20:05:18.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":840,"price":148.4018,"value":124657.512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.79 to $148.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":2940,"source":{"system":"sec-edgar","filing":"0001104659-26-084620","document":"tm2620681-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926084620/tm2620681-1_4seq1.xml","form_type":"4"}},{"id":706432,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-17T20:05:18.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":522,"price":147.1365,"value":76805.253,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.77 to $147.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":3780,"source":{"system":"sec-edgar","filing":"0001104659-26-084620","document":"tm2620681-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926084620/tm2620681-1_4seq1.xml","form_type":"4"}},{"id":706431,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-17T20:05:18.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-084620","document":"tm2620681-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926084620/tm2620681-1_4seq1.xml","form_type":"4"}},{"id":706430,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-17T20:05:18.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-084620","document":"tm2620681-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926084620/tm2620681-1_4seq1.xml","form_type":"4"}},{"id":730049,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T21:06:25.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":8592,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-076460","document":"tm2618468-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926076460/tm2618468-1_4seq1.xml","form_type":"4"}},{"id":730048,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-22T21:06:25.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":8627,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-076460","document":"tm2618468-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926076460/tm2618468-1_4seq1.xml","form_type":"4"}},{"id":730047,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T21:06:25.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":25,"price":112.23,"value":2805.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-076460","document":"tm2618468-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926076460/tm2618468-1_4seq1.xml","form_type":"4"}},{"id":730046,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T21:06:25.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":1887,"price":111.3128,"value":210047.2536,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.08 to $111.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":25,"source":{"system":"sec-edgar","filing":"0001104659-26-076460","document":"tm2618468-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926076460/tm2618468-1_4seq1.xml","form_type":"4"}},{"id":730045,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T21:06:25.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":2390,"price":110.2594,"value":263519.966,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.055 to $110.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":1912,"source":{"system":"sec-edgar","filing":"0001104659-26-076460","document":"tm2618468-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926076460/tm2618468-1_4seq1.xml","form_type":"4"}},{"id":730044,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T21:06:25.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-076460","document":"tm2618468-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926076460/tm2618468-1_4seq1.xml","form_type":"4"}},{"id":730043,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-22T21:06:25.000Z","date":"2026-06-17","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-076460","document":"tm2618468-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926076460/tm2618468-1_4seq1.xml","form_type":"4"}},{"id":765407,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-22T20:05:12.000Z","date":"2026-05-20","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":10740,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-065692","document":"tm2615383-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926065692/tm2615383-1_4seq1.xml","form_type":"4"}},{"id":765406,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-22T20:05:12.000Z","date":"2026-05-20","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":10781,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-065692","document":"tm2615383-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926065692/tm2615383-1_4seq1.xml","form_type":"4"}},{"id":765405,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:05:12.000Z","date":"2026-05-20","kind":"sale","planned":true,"acquired":false,"shares":48,"price":111.895,"value":5370.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-065692","document":"tm2615383-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926065692/tm2615383-1_4seq1.xml","form_type":"4"}},{"id":765404,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:05:12.000Z","date":"2026-05-20","kind":"sale","planned":true,"acquired":false,"shares":891,"price":111.2963,"value":99165.0033,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.89 to $111.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":48,"source":{"system":"sec-edgar","filing":"0001104659-26-065692","document":"tm2615383-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926065692/tm2615383-1_4seq1.xml","form_type":"4"}},{"id":765403,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:05:12.000Z","date":"2026-05-20","kind":"sale","planned":true,"acquired":false,"shares":3363,"price":110.3464,"value":371094.9432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $109.87 to $110.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":939,"source":{"system":"sec-edgar","filing":"0001104659-26-065692","document":"tm2615383-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926065692/tm2615383-1_4seq1.xml","form_type":"4"}},{"id":765402,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:05:12.000Z","date":"2026-05-20","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-065692","document":"tm2615383-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926065692/tm2615383-1_4seq1.xml","form_type":"4"}},{"id":765401,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-22T20:05:12.000Z","date":"2026-05-20","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-065692","document":"tm2615383-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926065692/tm2615383-1_4seq1.xml","form_type":"4"}},{"id":805169,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested."}],"balance_after":12888,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":805168,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option is fully vested."}],"balance_after":12935,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":805167,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":100,"price":130.33,"value":13033.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":805166,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":639,"price":129.1692,"value":82539.1188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $128.95 to $129.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":805165,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":561,"price":128.2349,"value":71939.7789,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $127.88 to $128.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":739,"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":805164,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":127.1254,"value":190688.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $126.77 to $127.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":805163,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"sale","planned":true,"acquired":false,"shares":1502,"price":125.9647,"value":189198.9794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $125.53 to $126.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":2800,"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":805162,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":805161,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-04-17T20:05:10.000Z","date":"2026-04-15","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-044895","document":"tm2612000-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926044895/tm2612000-1_4seq1.xml","form_type":"4"}},{"id":832009,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:05:15.000Z","date":"2026-03-18","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested."}],"balance_after":15036,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-032695","document":"tm269404-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926032695/tm269404-1_4seq1.xml","form_type":"4"}},{"id":832008,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-20T20:05:15.000Z","date":"2026-03-18","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested."}],"balance_after":15089,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-032695","document":"tm269404-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926032695/tm269404-1_4seq1.xml","form_type":"4"}},{"id":832007,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:05:15.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":304,"price":119.0817,"value":36200.8368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.08 to $119.3767, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-032695","document":"tm269404-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926032695/tm269404-1_4seq1.xml","form_type":"4"}},{"id":832006,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:05:15.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":1730,"price":118.3681,"value":204776.813,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.00 to $118.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":304,"source":{"system":"sec-edgar","filing":"0001104659-26-032695","document":"tm269404-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926032695/tm269404-1_4seq1.xml","form_type":"4"}},{"id":832005,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:05:15.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":2268,"price":117.5632,"value":266633.3376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.995 to $117.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":2034,"source":{"system":"sec-edgar","filing":"0001104659-26-032695","document":"tm269404-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926032695/tm269404-1_4seq1.xml","form_type":"4"}},{"id":832004,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:05:15.000Z","date":"2026-03-18","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-032695","document":"tm269404-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926032695/tm269404-1_4seq1.xml","form_type":"4"}},{"id":832003,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-20T20:05:15.000Z","date":"2026-03-18","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-032695","document":"tm269404-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926032695/tm269404-1_4seq1.xml","form_type":"4"}},{"id":890238,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:05:17.000Z","date":"2026-02-18","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":17184,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-018136","document":"tm266892-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926018136/tm266892-1_4seq1.xml","form_type":"4"}},{"id":890237,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-20T21:05:17.000Z","date":"2026-02-18","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":17243,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-018136","document":"tm266892-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926018136/tm266892-1_4seq1.xml","form_type":"4"}},{"id":890236,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:05:17.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":1276,"price":79.9651,"value":102035.4676,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.775 to $80.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-018136","document":"tm266892-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926018136/tm266892-1_4seq1.xml","form_type":"4"}},{"id":890235,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:05:17.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":3026,"price":79.1569,"value":239528.7794,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.75 to $79.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected."}],"balance_after":1276,"source":{"system":"sec-edgar","filing":"0001104659-26-018136","document":"tm266892-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926018136/tm266892-1_4seq1.xml","form_type":"4"}},{"id":890234,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:05:17.000Z","date":"2026-02-18","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-018136","document":"tm266892-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926018136/tm266892-1_4seq1.xml","form_type":"4"}},{"id":890233,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-20T21:05:17.000Z","date":"2026-02-18","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-018136","document":"tm266892-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926018136/tm266892-1_4seq1.xml","form_type":"4"}},{"id":914044,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-09T21:05:29.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":48956,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in equal monthly installments over 48 months commencing from February 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":48956,"derivative":{"exercise_price":76.43,"expiration_date":"2036-02-05","underlying":"Common Stock","underlying_shares":48956},"source":{"system":"sec-edgar","filing":"0001104659-26-012060","document":"tm265512-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926012060/tm265512-1_4seq1.xml","form_type":"4"}},{"id":932006,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-23T21:05:21.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."}],"balance_after":19332,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-26-006237","document":"tm263925-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926006237/tm263925-1_4seq1.xml","form_type":"4"}},{"id":932005,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-23T21:05:21.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."}],"balance_after":19397,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-26-006237","document":"tm263925-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926006237/tm263925-1_4seq1.xml","form_type":"4"}},{"id":932004,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:05:21.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":3749,"price":97.94,"value":367177.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-26-006237","document":"tm263925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926006237/tm263925-1_4seq1.xml","form_type":"4"}},{"id":932003,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:05:21.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":553,"price":95.49,"value":52805.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":3749,"source":{"system":"sec-edgar","filing":"0001104659-26-006237","document":"tm263925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926006237/tm263925-1_4seq1.xml","form_type":"4"}},{"id":932002,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:05:21.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-26-006237","document":"tm263925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926006237/tm263925-1_4seq1.xml","form_type":"4"}},{"id":932001,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-23T21:05:21.000Z","date":"2026-01-21","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-26-006237","document":"tm263925-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465926006237/tm263925-1_4seq1.xml","form_type":"4"}},{"id":961836,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T21:05:19.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during\nan open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in\naccordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons\nsuch as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested."}],"balance_after":21480,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-25-123109","document":"tm2534005-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925123109/tm2534005-1_4seq1.xml","form_type":"4"}},{"id":961835,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-19T21:05:19.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during\nan open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in\naccordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons\nsuch as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested."}],"balance_after":21551,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-25-123109","document":"tm2534005-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925123109/tm2534005-1_4seq1.xml","form_type":"4"}},{"id":961834,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:05:19.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":4302,"price":96.472,"value":415022.544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during\nan open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in\naccordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons\nsuch as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.34 to $96.82. The Reporting\nPerson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information\nregarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-123109","document":"tm2534005-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925123109/tm2534005-1_4seq1.xml","form_type":"4"}},{"id":961833,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:05:19.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during\nan open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in\naccordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons\nsuch as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-25-123109","document":"tm2534005-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925123109/tm2534005-1_4seq1.xml","form_type":"4"}},{"id":961832,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-12-19T21:05:19.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during\nan open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in\naccordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons\nsuch as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-25-123109","document":"tm2534005-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925123109/tm2534005-1_4seq1.xml","form_type":"4"}},{"id":991034,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-21T21:25:25.000Z","date":"2025-11-19","kind":"exercise","planned":true,"acquired":false,"shares":2148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":23628,"derivative":{"exercise_price":9.08,"expiration_date":"2030-10-14","underlying":"Common Stock","underlying_shares":2148},"source":{"system":"sec-edgar","filing":"0001104659-25-115017","document":"tm2531981-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925115017/tm2531981-1_4seq1.xml","form_type":"4"}},{"id":991033,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-21T21:25:25.000Z","date":"2025-11-19","kind":"exercise","planned":true,"acquired":false,"shares":2154,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":23705,"derivative":{"exercise_price":7.14,"expiration_date":"2029-10-29","underlying":"Common Stock","underlying_shares":2154},"source":{"system":"sec-edgar","filing":"0001104659-25-115017","document":"tm2531981-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925115017/tm2531981-1_4seq1.xml","form_type":"4"}},{"id":991032,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-21T21:25:25.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":2802,"price":86.5053,"value":242387.8506,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.485 to $86.97. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-115017","document":"tm2531981-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925115017/tm2531981-1_4seq1.xml","form_type":"4"}},{"id":991031,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-21T21:25:25.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":1500,"price":85.7183,"value":128577.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.475 to $86.08. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":2802,"source":{"system":"sec-edgar","filing":"0001104659-25-115017","document":"tm2531981-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925115017/tm2531981-1_4seq1.xml","form_type":"4"}},{"id":991030,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-21T21:25:25.000Z","date":"2025-11-19","kind":"exercise","planned":true,"acquired":true,"shares":2148,"price":9.08,"value":19503.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025."}],"balance_after":4302,"source":{"system":"sec-edgar","filing":"0001104659-25-115017","document":"tm2531981-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925115017/tm2531981-1_4seq1.xml","form_type":"4"}},{"id":991029,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-11-21T21:25:25.000Z","date":"2025-11-19","kind":"exercise","planned":true,"acquired":true,"shares":2154,"price":7.14,"value":15379.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025."}],"balance_after":2154,"source":{"system":"sec-edgar","filing":"0001104659-25-115017","document":"tm2531981-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000110465925115017/tm2531981-1_4seq1.xml","form_type":"4"}},{"id":1276088,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-02-10T22:40:29.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":123559,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in equal monthly tranches over 48 months"}],"balance_after":123559,"derivative":{"exercise_price":14.76,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":123559},"source":{"system":"sec-edgar","filing":"0001583648-25-000019","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000158364825000019/edgardoc.xml","form_type":"4/A","original_submission_date":"2025-02-07"}},{"id":1276087,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-02-10T22:40:29.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":5373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in equal monthly tranches over 48 months"}],"balance_after":5373,"derivative":{"exercise_price":14.76,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":5373},"source":{"system":"sec-edgar","filing":"0001583648-25-000019","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000158364825000019/edgardoc.xml","form_type":"4/A","original_submission_date":"2025-02-07"}},{"id":1328101,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":21165,"kind":"person","name":"Goin Kathleen","position":1,"cik":"0001912570","reported_name":"Goin Kathleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-18T01:43:33.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":27843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in equal monthly tranches over 48 months."}],"balance_after":27843,"derivative":{"exercise_price":13.6,"expiration_date":"2034-12-13","underlying":"Common Stock","underlying_shares":27843},"source":{"system":"sec-edgar","filing":"0001062993-24-020819","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1583648/000106299324020819/form4.xml","form_type":"4"}}]}